Skip to main content
Premium Trial:

Request an Annual Quote

Plexus to Commercially Manufacture Microsaic's Miniature Mass Spectrometer

NEW YORK (GenomeWeb) – Microsaic Systems and Plexus today announced an agreement for the commercial manufacturing of Microsaic's 4000MiD miniature mass spectrometry system.

The instrument was launched in March 2013 and Plexus was chosen for its expertise with complex sub-assemblies and its ability to provide engineering solutions to support current and future product developments. Microsaic also sought to keep production close to its own facility in Surrey, UK.

Microsaic Chief Executive Colin Jump said in a statement that Plexus is an "excellent strategic fit" for his company, and through the agreement, "we gain the ability to optimize and scale our manufacturing to meet the increasing demand for our product now and in the future."

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more